PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

Final trial results show durable T-cell responses and reduced relapse in patients with pancreatic and colorectal cancer

2025-08-12
(Press-News.org) A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results in patients with pancreatic and colorectal cancer, two of the most difficult-to-treat malignancies, according to a study led in part by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.

The findings, published in Nature Medicine, show that the vaccine, called ELI-002 2P, can trigger powerful and lasting immune responses and may help prevent or delay cancer recurrence in high-risk patients whose tumors are driven by KRAS mutations. After an extended follow-up of 19.7 months, the researchers found that median relapse-free survival was 16.33 months and median overall survival was 28.94 months—both exceeding historical norms— with the greatest benefit seen in patients who developed strong mKRAS-specific T cell responses. For example, median relapse-free survival was not reached versus 3.02 months, and median overall survival was not reached versus 15.98 months comparing the above versus below T cell threshold groups. 

“This is an exciting advance for patients with KRAS-driven cancers, particularly pancreatic cancer, where recurrence after standard treatment is almost a given and effective therapies are limited,” said first author of the study Zev Wainberg, MD, professor of medicine at the David Geffen School of Medicine at UCLA and researcher in the UCLA Health Jonsson Comprehensive Cancer Center. “We observed that patients who developed strong immune responses to the vaccine remained disease-free and survived for much longer than expected.”

The study, which included follow-up data from the AMPLIFY 201 Phase 1 trial, evaluated the safety and efficacy of a lymph node-directed vaccination that targets KRAS mutations. These mutations are found in about 25% of solid tumors and drive about 90% of pancreatic cancers and 50% of colorectal cancers.

Unlike some other cancer treatments that may need to be personalized for each patient based on their specific characteristics and mutations, ELI-002 2P is an “off-the-shelf” vaccine that is designed to be a standardized product that can stimulate the immune system to recognize and attack cancer cells in a general way, without the need for the time-consuming and complex process of creating a unique vaccine for each patient.

The study followed 25 patients with either pancreatic ductal adenocarcinoma (20) or colorectal cancer (5) who had undergone surgery and showed signs of minimal residual disease, or traces of cancer DNA in the blood that often signal relapse.

Each patient received a series of injections with ELI-002 2P, which uses an amphiphile technology developed by Elicio Therapeutics that helps shuttle antigens directly to the lymph nodes, where immune responses are activated. 

Among the findings:

84% of patients (21 out of 25) generated KRAS-specific T cells, including both CD4+ helper cells and CD8+ killer cells. Importantly, many of these T cells persisted over time. In 24% of patients (3 pancreatic, 3 colorectal), the biomarkers associated with the tumor were completely cleared. Patients with higher (above threshold) T-cell responses had a longer relapse-free survival compared to those with lower T-cell responses. In patients with higher responses, the median relapse-free survival was not reached, meaning so many patients were still cancer-free, a median time to relapse could not be calculated, versus 3.02 months (p=0.0002) in those with lower responses, and the median overall survival was not reached versus 15.98 months (p=0.0099) among those without strong T cell responses. 67% of tested patients developed immune responses to additional tumor-associated mutations, suggesting potential for broader anti-tumor activity.  “Targeting KRAS has long been considered one of the difficult challenges in cancer therapy,” said Wainberg. “This study shows that the ELI-002 2P vaccine can safely and effectively train the immune system to recognize and fight cancer-driving mutations. It offers a promising approach to generating precise and durable immune responses without the complexity or cost of fully personalized vaccines.”

The research team has completed enrollment in a larger Phase 2 study of ELI-002 7P, a next-generation version of the vaccine that targets a broader set of KRAS mutations. 

The study’s senior authors are Shubham Pant from the MD Anderson Cancer Center and Eileen O’Reilly from Memorial Sloan Kettering Cancer Center. A full list of authors can be found in the study.

The study was sponsored and funded by Elicio Therapeutics. 

END


ELSE PRESS RELEASES FROM THIS DATE:

New strategy to boost the effect of immunotherapy in the most aggressive form of lung cancer

2025-08-12
Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research Institute, in collaboration with researchers from the CIBERONC cancer research network. The study, published in Cell Reports Medicine, highlights the role of HGF (hepatocyte growth factor)—which is linked to cell proliferation and survival—in the poor prognosis of this disease and its resistance to treatment. The research explores a novel approach that adds a MET inhibitor to standard therapy and demonstrates improved treatment response. Small cell lung cancer is one of the most aggressive ...

Counties with animal feeding operations have more air pollution, less health insurance coverage

2025-08-12
There are more than 15,000 cattle and hog feeding operations in the United States. These operations rear 70% of the country's cattle and 98% of its hogs.  Now, for the first time in the nation's history, we know with certainty where most of them are, thanks to research from the University of Michigan. The research team found that a quarter of the nation's hog and cattle feeding operations  are found in just 30 counties out of more than 3,000 in the United States. Going a step further, the team also found that an air pollutant linked to heart and respiratory issues near these animal feeding operations, ...

Mirror-like graphite films break records in strength and conductivity

2025-08-12
Graphite has attracted global interest due to its unique anisotropic properties, including excellent electrical and thermal conductivity. Widely used as a battery anode material and in applications such as electromagnetic shielding, catalysis, and nuclear technology, graphite remains a critical material in both industrial and research fields. For decades, researchers have sought to produce high-quality artificial graphite with large grains and smooth, layered structures. Conventional methods typically involve high-temperature treatment of polymer ...

AI uncovers new antibiotics in ancient microbes

2025-08-12
They’ve survived for billions of years in boiling acid, deep-sea vents and salt flats. Now, some of Earth’s oldest life forms — microbes called Archaea — are offering a new weapon in the fight against one of today’s most urgent health threats: antibiotic resistance.  In a new study published in Nature Microbiology, researchers at the University of Pennsylvania used artificial intelligence to identify previously unknown compounds in Archaea that could fuel the development ...

AI meets CRISPR for precise gene editing

2025-08-12
A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining cutting-edge genetic engineering with artificial intelligence. This technique opens the door to more accurate modeling of human diseases and lays the groundwork for next-generation gene therapies. Precise and targeted DNA editing by small point mutations as well as the integration of whole genes via CRISPR/Cas technology has great potential for applications in biotechnology and gene therapy. However, it is very important that the so-called “gene scissors” do not cause any unintended ...

New method to synthesize carbohydrates could pave the way to biomedical advances

2025-08-12
New method to synthesize carbohydrates could pave the way to biomedical advances (Santa Barbara, Calif.) — Carbohydrate is a familiar term. It’s the bagel you had for breakfast, the bread in your sandwich, the slice of cake you’re thinking about sneaking later today. But carbs aren’t only in baked goods, and they’re not just found in foods. Small yet structurally complex carbohydrates serve as elements of cell walls and are important in intercellular interactions. Scientists can quickly and reliably make many biomolecules, from DNA to proteins, using automated instruments. So it may come as a surprise that for decades, scientists have had major difficulty ...

Plants feed through one-way routes

2025-08-12
Plants transport water and nutrients from their environment through specialised pores. Researchers at the University of Geneva (UNIGE) have shed light on a little-known but essential mechanism for proper plant function: the directionality of nutrient transport in roots. The team demonstrates that this transport becomes unidirectional as the root develops. This discovery highlights the central role of the pores connecting plant cells and opens up new perspectives for improving plant resistance to water stress. These findings are published in the journal Molecular Plant. Roots play ...

3D-printed kidney tumors show potential for more targeted treatment

2025-08-12
Scientists at Tsinghua University have developed a method to grow kidney tumours in the lab using cells from real patients, offering a potential new tool in the fight against renal cancer. Their research, published in the journal Biofabrication, outlines how 3D bioprinting technology can be used to replicate the unique characteristics of each patient’s tumour. The team combined tumour cells with other cell types, including blood vessel-like structures, to mimic the environment within the body. The lab-grown tumours, called organoids, are created from real patients’ tumour cells, and exactly mimic their traits. ...

Cats with dementia share hallmarks of humans with Alzheimer’s

2025-08-12
Cats with dementia have brain changes similar to those of people with Alzheimer’s disease, offering a valuable model for studying the condition in humans, a study says. Scientists discovered a build-up of the toxic protein amyloid-beta in the brains of cats with the condition – one of the defining features of Alzheimer’s disease. The findings offer a clearer picture of how amyloid-beta may lead to age-related brain dysfunction and memory loss in cats, experts say. Many older cats develop dementia, leading to behavioural changes such as increased vocalisation – or meowing – confusion and disrupted sleep ...

AI could soon detect early voice box cancer from the sound of your voice

2025-08-12
Cancer of the voice box or larynx is an important public health burden. In 2021, there were an estimated 1.1 million cases of laryngeal cancer worldwide, and approximately 100,000 people died from it. Risk factors include smoking, alcohol abuse, and infection with human papillomavirus. The prognosis for laryngeal cancer ranges from 35% to 78% survival over five years when treated, depending on the tumor’s stage and its location within the voice box. Catching cancer early is key for a patient’s prospects. At present, laryngeal cancers are diagnosed through video nasal endoscopy and biopsies ...

LAST 30 PRESS RELEASES:

Calorie labelling linked to 2% average reduction in energy content of menu items

Widely prescribed opioid painkiller tramadol not that effective for easing chronic pain

Exercise snacks may boost cardiorespiratory fitness of physically inactive adults

15,000 women a year with breast cancer could benefit from whole genome sequencing, say researchers

Study highlights risks of Caesarean births to future pregnancies

GLP-1 agonists pose emerging challenge for PET-CT imaging, study finds

Scripps Research scientists unlock new patterns of protein behavior in cell membranes

Panama Canal may face frequent extreme water lows in coming decades

Flash Joule heating lights up lithium extraction from ores

COMBINEDBrain and MUSC announce partnership to establish biorepository for pediatric cerebrospinal fluid and CNS tissue bank

Questionable lead reporting for drinking water virtually vanished after Flint water crisis, study reveals

Assessing overconfidence among national security officials

Bridging two frontiers: Mitochondria & microbiota, Targeting Extracellular Vesicles 2025 to explore game-changing pathways in medicine

New imaging tech promises to help doctors better diagnose and treat skin cancers

Once dominant, US agricultural exports falter amid trade disputes and rising competition

Biochar from invasive weed shields rice from toxic nanoplastics and heavy metals

Rice University announces second cohort of Chevron Energy Graduate Fellows

Soil bacteria and minerals form a natural “battery” that breaks down antibiotics in the dark

Jamestown colonists brought donkeys, not just horses, to North America, old bones reveal

FIU cybersecurity researchers develop midflight defense against drone hijacking

Kennesaw State researcher aims to discover how ideas spread in the digital age

Next-generation perovskite solar cells are closer to commercial use

Sleep patterns linked to variation in health, cognition, lifestyle, and brain organization

University of Oklahoma researcher awarded funding to bridge gap between molecular data and tissue architecture

Nationally-recognized pathologist Paul N. Staats, MD, named Chair of Pathology at University of Maryland School of Medicine

The world’s snow leopards are very similar genetically. That doesn’t bode well for their future

Researchers find key to stopping deadly infection

Leafcutter ants have blind spots, just like truck drivers

Tayac receives funding for community engagement project

Parker receives funding for Elementary Education Program Professional Development School (PDS)

[Press-News.org] Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
Final trial results show durable T-cell responses and reduced relapse in patients with pancreatic and colorectal cancer